Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 29 February

Sam Kanaan
February 29, 2024

Morning Bell 28 February

Grady Wulff
February 28, 2024

Morning Bell 27 February

Grady Wulff
February 27, 2024

Morning Bell 26 February

Grady Wulff
February 26, 2024

Weekly Wrap 23 February

Grady Wulff
February 23, 2024

Morning Bell 22 February

Sam Kanaan
February 22, 2024

Morning Bell 21 February

Grady Wulff
February 21, 2024

Morning Bell 20 February

Grady Wulff
February 20, 2024

Morning Bell 19 February

Grady Wulff
February 19, 2024

Weekly Wrap 16 February

Sophia Mavridis
February 16, 2024